Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032

Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032

The global genomics in cancer care market size is expected treach USD 72.87 billion by 2032, according ta new study by Polaris Market Research. The report “Genomics in Cancer Care Market Share, Size, Trends, Industry Analysis Report, By Product (Consumable, Instrument and Services); By Technology; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

The market is primarily driven by the increasing prevalence of cancer patients globally, and rising demand for diagnostics coupled with the availability of cost-effective and technologically advanced technology. Additionally, awareness and growing preference for personalized medicines is alsinfluencing the market growth. Moreover, continuous investment in research and developments by the biotechnology & pharmaceutical companies would alsfuel the market growth.

The Covid-19 epidemic has drastically altered the healthcare business as a whole, and its effects may be seen in many areas of the industry. Tcreate an effective vaccine or cutting-edge therapy for COVID-19, both the government and commercial pharmaceutical and biotechnology businesses have intensified their research operations and raised their funding.

Monitoring the coronavirus genome sequence can assist determine how an infection spreads and what effects it has on the human genome. With this knowledge, an infectious treatment strategy may subsequently be created. Researchers are tracing the genesis of COVID-19 infection in their nations and the start of community transmission using the viral genome data.

Genome sequencing has enormous potential, which has led tan increase in start-ups in recent years. Several businesses have begun offering sequencing services for a range of purposes, including nutrition, ancestry, genetic illnesses, and others, as a result of the enormous potential presented by genome sequencing. It is anticipated that start-up companies would receive more capital, which will help the industry expand.

For instance, consumer genomics business Ancestry is expected tprovide a new product with next-generation sequencing in August 2020. Ancestry Health, a new solution driven by Next Generation Sequencing (NGS) that promises tgive clients insights inttheir health and risk factors, may check for genes linked tblood diseases, colon cancer, breast cancer, and heart disease.

Genomics in Cancer Care Market Report Highlights

Instruments hold the major share in the market owing tthe rapid technological advancements and continuous efforts by the manufacturers for providing digitalization in the instruments for easy use.

Genome sequencing holds the major market share and would continue texperience growth during the forecast period. The growth in this segment is majorly driven by the effective and precise diagnosis results and rising awareness for its use in cancer diagnosis

Diagnostics application holds the largest market share which is majorly attributed tthe growing number of cancer patients worldwide.

North America holds a dominating position in the global market followed by Europe and Asia Pacific. The market growth in North America is driven by the presence of refined research & development infrastructure for the researchers, a large pool of patients suffering from cancer, and high healthcare expenditure by individuals.

The global key market players include Agilent Technologies, Roche Diagnostics, Beckman Coulter, Illumina, Inc., Affymetrix, Cancer Genetic Inc., Bio-Rad Labs, Pacific Bio-science, Sigma Aldrich Corporation, GE Healthcare, Quest Diagnostics, Abbott Laboratories, PerkinElmer, and Luminex.

Polaris Market Research has segmented the Genomics in Cancer Care market report based on product, technology, application, end-use, and region:

Genomics in Cancer Care, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Consumable

Instrument

services

Genomics in Cancer Care, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

Gene Sequencing

PCR

Microarray Nucleic Acid Extraction and Purification

Genomics in Cancer Care, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Diagnostics

Personalized Medicines

Drug Delivery

Research

Genomics in Cancer Care, End-use (Revenue - USD Billion, 2019 - 2032)

Hospitals

Research Institutes

Academic Research

Genomics in Cancer Care, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa